Three
"field-effect" biomarkers, which are used to detect prostate cancer
in tissue adjacent to histologically negative biopsies, might also be
indicative of occult aggressive cancers, according to a study presented at the
2013 Genitourinary Cancers Symposium (GUCS) in Orlando, Florida.

Like MD Anderson’s aggressive
pricing for Sean Recchi’s stay, Sloan-Kettering’s markup on drugs like the
Flebogamma given to Alan A. is one reason cancer care is so profitable. In
2011, the hospital and research institution of Sloan-Kettering had an operating
profit of $406 million even after everything it spent on research and the
education of a small army of young cancer doctors

After being
nursed and handed over, the baby’s wails rise to a tremolo, but I am determined
to give my exhausted daughter and son-in-law a respite on this wintry evening.
Commiserating with the little guy’s discomfort — gas, indigestion, colic,
ontological insecurity — I swaddle, burp, bink, then cradle him in my arms. I
begin walking around the house, swinging and swaying while cooing in soothing
cadences: “Yes, darling boy, another one bites the dust, another one bites the
dust.”